Prelude Capital Management, LLC Epizyme, Inc. Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$11.73 - $16.25 $244,124 - $338,195
-20,812 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$13.68 - $20.46 $29,808 - $44,582
2,179 Added 11.69%
20,812 $334,000
Q1 2020

May 15, 2020
BUY
$14.83 - $26.72 $53,832 - $96,993
3,630 Added 24.2%
18,633 $289,000
Q4 2019

Feb 14, 2020
BUY
$9.77 - $24.6 $139,720 - $351,804
14,301 Added 2037.18%
15,003 $369,000
Q3 2019

Nov 14, 2019
SELL
$10.17 - $13.86 $732,219 - $997,892
-71,998 Reduced 99.03%
702 $7,000
Q2 2019

Aug 14, 2019
BUY
$11.43 - $15.12 $820,159 - $1.08 Million
71,755 Added 7593.12%
72,700 $912,000
Q1 2019

May 15, 2019
SELL
$5.98 - $13.98 $1,512 - $3,536
-253 Reduced 21.12%
945 $12,000
Q4 2018

Feb 14, 2019
BUY
$5.22 - $10.44 $3,351 - $6,702
642 Added 115.47%
1,198 $7,000
Q3 2018

Nov 14, 2018
BUY
$9.5 - $13.75 $5,282 - $7,645
556 New
556 $6,000

About Epizyme, Inc.

EPZM Quotes by TradingView
  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email